Cannabis Use and the Course of Schizophrenia: 10-Year Follow-Up After First Hospitalization
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The authors examined the relationship between cannabis use and the course of illness in schizophrenia over 10 years of follow-up after first psychiatric hospitalization. METHOD: The authors assessed 229 patients with a schizophrenia spectrum disorder five times: during the first admission and 6 months, 2 years, 4 years, and 10 years later. Ratings of cannabis use and psychiatric symptoms (psychotic, negative, disorganized, and depressive) were made at each assessment. RESULTS: The lifetime rate of cannabis use was 66.2%, and survival analysis revealed that lifetime use was associated with an earlier onset of psychosis. The rates of current use ranged from 10% to 18% across assessments. Cannabis status was moderately stable, with tetrachoric correlation coefficients between waves ranging from 0.48 to 0.78. Mixed-effects logistic regression revealed that changes in cannabis use were associated with changes in psychotic symptoms over time even after gender, age, socioeconomic status, other drug use, antipsychotic medication use, and other symptoms were controlled for. Structural equation modeling indicated that the association with psychotic symptoms was bidirectional. CONCLUSIONS: Cannabis use is associated with an adverse course of psychotic symptoms in schizophrenia, and vice versa, even after taking into account other clinical, substance use, and demographic variables.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hu, L., & Bentler, P. M. (1999) · Structural Equation Modeling A Multidisciplinary Journal · doi:10.1080/10705519909540118 · Cited by 108,788
Missing data: our view of the state of the art
Schafer, J. L., & Graham, J. W. (2002) · Psychological Methods · doi:10.1037/1082-989x.7.2.147 · Cited by 11,638
Exploring the association between cannabis use and depression.
Degenhardt, L., Hall, W., & Lynskey, M. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00437.x · Cited by 587
Prevalence of Marijuana Use Disorders in the United States: 1991-1992 and 2001-2002
Compton, W. M., Grant, B. F., Colliver, J. D., Glantz, M. D., & Stinson, F. S. (2004) · JAMA · doi:10.1001/jama.291.17.2114 · Cited by 537
Cannabis use predicts future psychotic symptoms, and vice versa
Ferdinand, R. F., Sondeijker, F., Van Der Ende, J., Selten, J., Huizink, A., & Verhulst, F. C. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01070.x · Cited by 212
Cannabis use and psychosis: A review of clinical and epidemiological evidence
Hall, W., & Degenhardt, L. (2000) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2000.00685.x · Cited by 183
Psychotic symptom and cannabis relapse in recent-onset psychosis: Prospective study
Hides, L., Dawe, S., Kavanagh, D. J., & Young, R. M. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.bp.105.014308 · Cited by 166
Research works printed but not linked: 29
- 10.1192/bjp.187.4.306 · DOI · Paper page
- 10.1192/bjp.184.2.110 · DOI · Paper page
- 10.1111/j.1360-0443.2004.00683.x · DOI · Paper page
- 10.1002/j.2051-5545.2008.tb00158.x · DOI · Paper page
- 10.1080/j.1440-1614.2000.00736.x · doi:10.1080/j.1440-1614.2000.00736.x · Paper page
- 10.1176/appi.ajp.161.3.501 · DOI · Paper page
- 10.1016/S0376-8716(03)00064-4 · DOI · Paper page
- 10.1097/YCO.0b013e3282f51266 · DOI
- 10.1093/schbul/16.1.69 · DOI · Paper page
- 10.1007/s00406-002-0366-5 · DOI · Paper page
- 10.1111/j.1600-0447.1992.tb01456.x · DOI · Paper page
- 10.1017/S0033291700010278 · DOI · Paper page
- 10.1192/bjp.bp.107.046375 · DOI · Paper page
- 10.1007/s004060050064 · DOI
- Arias Horcajadas F, 2002, Actas Esp Psiquiatr, 30, 65
- 10.1016/j.eurpsy.2004.09.013 · DOI · Paper page
- 10.1017/S0033291707009956 · DOI · Paper page
- 10.1017/S0033291700030324 · DOI · Paper page
- 10.1093/schbul/18.2.243 · DOI · Paper page
- 10.1001/archpsyc.57.6.593 · DOI · Paper page
- Andreasen NC : Scale for the Assessment of Negative Symptoms (SANS). Iowa City, University of Iowa, 1983 · DOI · Paper page
- 10.1016/S0920-9964(98)00011-5 · DOI · Paper page
- 10.1093/schbul/sbn066 · DOI · Paper page
- 10.1176/ajp.157.1.60 · DOI · Paper page
- Verbeke G , Molenberghs G : Linear Mixed Models for Longitudinal Data. New York, Springer-Verlag, 2000 · DOI · Paper page
- 10.1080/03610739208253917 · DOI · Paper page
- 10.1007/s11920-003-0066-5 · DOI
- 10.1176/appi.ps.52.4.469 · DOI · Paper page
- Tiet QQ, 2007, Alcohol Clin Exp Res, 31, 513, 10.1111/j.1530-0277.2007.00336.x · DOI · Paper page
Cited by
Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis
Marconi, A., Di Forti, M., Lewis, C. M., Murray, R. M., & Vassos, E. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw003 · Cited by 899
Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review
Volkow, N. D., Swanson, J. M., Evins, A. E., DeLisi, L. E., Meier, M. H., Gonzalez, R., Bloomfield, M. A. P., Curran, H. V., & Baler, R. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.3278 · Cited by 867
Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review
Ochoa, S., Usall, J., Cobo, J., Labad, X., & Kulkarni, J. (2012) · Schizophrenia Research and Treatment · doi:10.1155/2012/916198 · Cited by 735
“In the case of first-episode psychosis, men had a higher prevalence of cannabis use than women [29, 64, 66, 67].”
BackgroundHunt, G. E., Large, M. M., Cleary, M., Lai, H. M. X., & Saunders, J. B. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.07.011 · Cited by 482
The Pharmacologic and Clinical Effects of Medical Cannabis
Borgelt, L. M., Franson, K. L., Nussbaum, A. M., & Wang, G. S. (2013) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1187 · Cited by 423
Prefrontal Cortical Dendritic Spine Pathology in Schizophrenia and Bipolar Disorder
Konopaske, G. T., Lange, N., Coyle, J. T., & Benes, F. M. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1582 · Cited by 379
Schoeler, T., Monk, A., Sami, M. B., Klamerus, E., Foglia, E., Brown, R., Camuri, G., Altamura, A. C., Murray, R., & Bhattacharyya, S. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00363-6 · Cited by 322
Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): I. Psychosis superspectrum
Kotov, R., Jonas, K. G., Carpenter, W. T., Dretsch, M. N., Eaton, N. R., Forbes, M. K., Forbush, K. T., Hobbs, K., Reininghaus, U., Slade, T., et al. (2020) · World Psychiatry · doi:10.1002/wps.20730 · Cited by 309
Self-citationSynthetic cannabinoid JWH-018 and psychosis: An explorative study
Every-Palmer, S. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.01.012 · Cited by 299
Degenhardt, L., Ferrari, A. J., Calabria, B., Hall, W. D., Norman, R. E., McGrath, J., Flaxman, A. D., Engell, R. E., Freedman, G. D., Whiteford, H. A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076635 · Cited by 298
A systematic review of the antipsychotic properties of cannabidiol in humans
Iseger, T. A., & Bossong, M. G. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.01.033 · Cited by 261
Blurred Boundaries: The Therapeutics and Politics of Medical Marijuana
Bostwick, J. M. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2011.10.003 · Cited by 261
Cannabis and mental illness: a review
Lowe, D. J. E., Sasiadek, J. D., Coles, A. S., & George, T. P. (2019) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-018-0970-7 · Cited by 253
Genetic predisposition to schizophrenia associated with increased use of cannabis
Power, R. A., Verweij, K. J. H., Zuhair, M., Montgomery, G. W., Henders, A. K., Heath, A. C., Madden, P. A. F., Medland, S. E., Wray, N. R., & Martin, N. G. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.51 · Cited by 196
Psychosis breakthrough on antipsychotic maintenance: results from a nationwide study
Rubio, J. M., Taipale, H., Correll, C. U., Tanskanen, A., Kane, J. M., & Tiihonen, J. (2020) · Psychological Medicine · doi:10.1017/s0033291719001296 · Cited by 45
“Epidemiologic studies of schizophrenia have found that worse premorbid functioning (Robinson et al., 1999), cannabis use (Foti et al., 2010), and treatment with first-generation antipsychotics (FGAs) (Mojtabai et al., 2003), are associated with greater risk of relapse after controlling for…”
BackgroundAthanassiou, M., Dumais, A., Gnanhoue, G., Abdel-Baki, A., Jutras-Aswad, D., & Potvin, S. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1942845 · Cited by 29
Feingold, D., Rehm, J., Factor, H., Redler, A., & Lev‐Ran, S. (2018) · Depression and Anxiety · doi:10.1002/da.22735 · Cited by 24
The Changing Legal Landscape of Cannabis Use and Its Role in Youth-onset Psychosis
Wright, A., Cather, C., Gilman, J., & Evins, A. E. (2020) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2019.08.016 · Cited by 16
Metadata
- Authors
- Foti, D. J., Kotov, R., Guey, L. T., & Bromet, E. J.
- Venue
- American Journal of Psychiatry
- Published
- 2010-08-01
- Volume
- 167
- Issue
- 8
- Pages
- 987-993
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2111161766
- Cited by
- 223
- References
- 7
- FWCI
- 11.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.